HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Oxyphenbutazone
Description
Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
Company not known
Reozon
